HomeProductsBioactive CompoundsEpigeneticsSirtuinSrt-2104
Chemical structure of CAS 1093403-33-8

Srt-2104

CAS No.1093403-33-8
MDL No.MFCD22572733
MFC26H24N6O2S2
MW516.60
InChI KeyLAMQVIQMVKWXOC-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1093403-33-8
Product NameSrt-2104

Biological Targets

SIRT1

Associated Conditions

type 2 diabetes mellitus·chronic obstructive pulmonary disease·psoriasis·ulcerative colitis·Sepsis·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.

Inflammatory bowel diseases • Vol. 22, Issue 3 • 2016
PMID: 26595549PMC: PMC4885523DOI: 10.1097/MIB.0000000000000597

A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis.

PloS one • Vol. 10, Issue 11 • 2015
PMID: 26556603PMC: PMC4640558DOI: 10.1371/journal.pone.0142081

Sirtuin 1 activator SRT2104 protects Huntington's disease mice.

Annals of clinical and translational neurology • Vol. 1, Issue 12 • 2014
PMID: 25574479PMC: PMC4284130DOI: 10.1002/acn3.135

Documentation